ratio-methotrexate sodium tablet
teva canada limited - methotrexate (methotrexate sodium) - tablet - 2.5mg - methotrexate (methotrexate sodium) 2.5mg - antineoplastic agents
methotrexate pf/sa injection solution
sandoz canada incorporated - methotrexate (methotrexate sodium) - solution - 25mg - methotrexate (methotrexate sodium) 25mg - antineoplastic agents
methotrexate 50mg/2ml solution for injection vials
pfizer ltd - methotrexate sodium - solution for injection - 25mg/1ml
methotrexate 500mg/20ml solution for injection vials
pfizer ltd - methotrexate sodium - solution for injection - 25mg/1ml
pms-methotrexate tablet
pharmascience inc - methotrexate (methotrexate disodium) - tablet - 2.5mg - methotrexate (methotrexate disodium) 2.5mg - antineoplastic agents
m-methotrexate tablet
mantra pharma inc - methotrexate (methotrexate disodium) - tablet - 2.5mg - methotrexate (methotrexate disodium) 2.5mg
methotrexate tablets, usp
pfizer canada ulc - methotrexate - tablet - 10mg - methotrexate 10mg - antineoplastic agents
methotrexate tablet
apotex inc - methotrexate (methotrexate sodium) - tablet - 2.5mg - methotrexate (methotrexate sodium) 2.5mg - antineoplastic agents
methotrexate injection, usp solution
strides pharma canada inc - methotrexate (methotrexate sodium) - solution - 25mg - methotrexate (methotrexate sodium) 25mg - antineoplastic agents
methotrexate- methotrexate injection, solution
teva parenteral medicines, inc. - methotrexate sodium (unii: 3ig1e710zn) (methotrexate - unii:yl5fz2y5u1) - methotrexate is indicated in the treatment of gestational choriocarcinoma, chorioadenoma destruens and hydatidiform mole. in acute lymphocytic leukemia, methotrexate is indicated in the prophylaxis of meningeal leukemia and is used in maintenance therapy in combination with other chemotherapeutic agents. methotrexate is also indicated in the treatment of meningeal leukemia. methotrexate is used alone or in combination with other anticancer agents in the treatment of breast cancer, epidermoid cancers of the head and neck, advanced mycosis fungoides (cutaneous t cell lymphoma), and lung cancer, particularly squamous cell and small cell types. methotrexate is also used in combination with other chemotherapeutic agents in the treatment of advanced stage non-hodgkin's lymphomas. methotrexate in high doses followed by leucovorin rescue in combination with other chemotherapeutic agents is effective in prolonging relapse-free survival in patients with non-metastatic osteosarcoma who have undergone surgical resection